Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Panacea Biotec Ltd. Major Shareholding Notification 2023

Aug 10, 2023

62573_rns_2023-08-10_e99fc578-78b6-49e0-a675-577c9d641ccf.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

==> picture [143 x 65] intentionally omitted <==

Date: 10.08.2023

The Manager, Listing Department The National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 NSE Symbol : PANACEABIO

BSE Limited Corporate Relationship Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 BSE Scrip Code: 531349

Sub: Disclosure under Regulation 30 read with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of request seeking re-classification from ‘Promoter & Promoters’ Group’ category to ‘Public’ category of Panacea Biotec Limited (“the Company”)

Dear Sir/Madam,

With regard to the captioned subject, we hereby inform you the Company has received request letters on 09.08.2023, from the following shareholders who are presently part of the Promoters’ Group (each referred to as “Outgoing Promoter Group Member”), requesting to re-classify them from “Promoters and Promoters’ Group” category to “Public” category, in accordance with the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”):

S. No. Name of the Outgoing PromoterGroup Member No. of shares held % of shareholding
1. Ms. Sunanda Jain 0 -
2. Mr. Sumit Jain 0 -
3. Ms. Radhika Jain 0 -
4. Mr. Abhey Kumar Jain 0 -

The requests received from the Outgoing Promoter Group Members will be considered by the Board of Directors of the Company at the Board Meeting scheduled to be held on Saturday, 12[th] August, 2023.

The necessary steps will be undertaken by the Company in compliance with Regulation 31A of the SEBI LODR Regulations in due course.

Kindly take the above on record and oblige.

Thanking you,

Yours Sincerely

For Panacea Biotec Limited

VINOD Digitally signed by VINOD GOEL GOEL Date: 2023.08.10 14:16:39 +05'30'

Vinod Goel

Group CFO and Head Legal and Company Secretary

Panacea Biotec Ltd (CIN: L33117PB1984PLC022350)

Regd. Office : Ambala Chandigarh Higway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn../G-3, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9070 Email: [email protected]